Biogen acquired Reata Pharmaceuticals for $7.3 billion on June 26, 2025.
1 report, 0 independent
Updated Jun 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Biogen acquired Reata Pharmaceuticals for $7.3 billion on June 26, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Biogen
American multinational biotechnology company
Nothing else this week.
-
Reata Pharmaceuticals
pharmaceutical company focused on investigating experimental oral antioxidative and anti-inflammatory drugs
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- Unknown outlet